Meager A - Search Results

1

Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model.

Benjamin R, Khwaja A, Singh N, McIntosh J, Meager A, Wadhwa M, Streck C, Ng C, Davidoff AM, Nathwani AC. Benjamin R, et al. Among authors: meager a. Blood. 2007 Feb 1;109(3):1244-7. doi: 10.1182/blood-2006-02-002915. Epub 2006 Oct 17. Blood. 2007. PMID: 17047156 Free article.

2

Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons?

Meager A, Cludts I, Thorpe R, Wadhwa M. Meager A, et al. Blood. 2010 Jan 14;115(2):433-4. doi: 10.1182/blood-2009-08-241018. Blood. 2010. PMID: 20075174 Free article. No abstract available.

3

Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2.

Limb GA, Meager A, Woolley J, Wadhwa M, Biggerstaff J, Brown KA, Wolstencroft RA. Limb GA, et al. Among authors: meager a. Immunology. 1989 Dec;68(4):514-9. Immunology. 1989. PMID: 2514140 Free PMC article.

4

Biological activity of interleukins-28 and -29: comparison with type I interferons.

Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M. Meager A, et al. Cytokine. 2005 Jul 21;31(2):109-18. doi: 10.1016/j.cyto.2005.04.003. Cytokine. 2005. PMID: 15899585

5

In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.

Heslop HE, Gottlieb DJ, Bianchi AC, Meager A, Prentice HG, Mehta AB, Hoffbrand AV, Brenner MK. Heslop HE, et al. Among authors: meager a. Blood. 1989 Sep;74(4):1374-80. Blood. 1989. PMID: 2504308 Free article. Clinical Trial.

6

Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA.

Moore M, Meager A, Wadhwa M, Burns C. Moore M, et al. Among authors: meager a. J Pharm Biomed Anal. 2009 Feb 20;49(2):534-9. doi: 10.1016/j.jpba.2008.11.010. Epub 2008 Nov 19. J Pharm Biomed Anal. 2009. PMID: 19097723

7

Detection of anti-cytokine antibodies and their clinical relevance.

Meager A, Wadhwa M. Meager A, et al. Expert Rev Clin Immunol. 2014 Aug;10(8):1029-47. doi: 10.1586/1744666X.2014.918848. Epub 2014 Jun 5. Expert Rev Clin Immunol. 2014. PMID: 24898469 Review.

8

Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.

Cludts I, Meager A, Thorpe R, Wadhwa M. Cludts I, et al. Among authors: meager a. J Immunol Methods. 2013 Sep 30;395(1-2):37-44. doi: 10.1016/j.jim.2013.06.008. Epub 2013 Jul 2. J Immunol Methods. 2013. PMID: 23831137 Free article.

9

Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus.

Duncombe AS, Meager A, Prentice HG, Grundy JE, Heslop HE, Hoffbrand AV, Brenner MK. Duncombe AS, et al. Among authors: meager a. Blood. 1990 Sep 1;76(5):1046-53. Blood. 1990. PMID: 2168224 Free article.

10

A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.

McClements M, Williams S, Ball C, Bristow A, Wadhwa M, Meager A. McClements M, et al. Among authors: meager a. J Immunol Methods. 2008 Aug 20;337(1):63-70. doi: 10.1016/j.jim.2008.05.013. Epub 2008 Jun 11. J Immunol Methods. 2008. PMID: 18625509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters